マルチプレックスアッセイ市場：タイプ（タンパク質、核酸、細胞）技術（フローサイトメトリー、PCR、イムノアッセイ）用途（研究開発、診断製品）、エンドユーザー別-2030年までの世界予測

マルチプレックスアッセイの世界市場は、2023年から2030年までのCAGRが9.0%で、2030年までに62億4,000万米ドルに達すると予測されます。

本レポートは、広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、主要な業界促進要因、抑制要因、課題、機会の分析から構成されています。この市場の成長は、シングルプレックスアッセイに対するマルチプレックスアッセイの優位性、コンパニオン診断におけるマルチプレックスアッセイの利用、慢性疾患や感染症の有病率の増加、早期疾患診断の重要性に対する意識の高まりなど、いくつかの要因に起因しています。しかし、マルチプレックスアッセイ装置のコストが高いことが市場の成長を抑制しています。

ハイスループットで自動化された検査システムに対するニーズの高まりと個別化医療への注目の高まりは、この市場で事業を展開するプレーヤーに成長機会をもたらすと期待されています。しかし、熟練した専門家の不足と交差反応性のリスクは、市場成長の大きな課題です。

本レポートは、製品ポートフォリオの提供、地域的プレゼンス、および業界をリードする市場プレイヤーが数年間（2020-2023年）に採用した主な戦略的発展の広範な評価に基づく競合情勢を提供しています。世界のマルチプレックスアッセイ市場で事業を展開している主要企業は、Thermo Fisher Scientific, Inc.（米国）、Bio-Rad Laboratories, Inc.（米国）、Seegene, Inc.（韓国）、Qiagen N.V.（オランダ）、PerkinElmer, Inc.（米国）、F. Hoffmann-La Roche Ltd.（スイス）、Agilent Technologies, Inc. Ltd.（スイス）、Agilent Technologies, Inc.（米国）、Abbott Laboratories（米国）、Siemens Healthineers AG（ドイツ）、Illumina, Inc.（米国）、Becton, Dickinson and Company（米国）、Quanterix Corporation（米国）、DiaSorin S.p.A.（イタリア）、Merck KGaA（ドイツ）。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

市場
• 概要
• 市場成長に影響を与える要因
  • 市場力学
    • マルチプレックスアッセイのシングルプレックスアッセイに対する優位性が、マルチプレックスアッセイの採用拡大につながる
    • コンパニオン診断におけるマルチプレックスアッセイの利用の拡大がマルチプレックスアッセイの需要を牽引
    • マルチプレックスアッセイ装置の高コストがエンドユーザーへの普及を妨げる
    • 個別化医療への関心の高まりがマルチプレックスアッセイの利用を後押し
    • 熟練した専門家の不足と交差反応のリスクがマルチプレックスアッセイの採用を制限する
  • 要因分析
• 技術動向
  • マルチプレックスPCR技術の技術的進歩
  • マルチプレックスアッセイシステムへの人工知能と機械学習の統合
  • スマートフォンベースの診断検査プラットフォームの開発
• 規制分析
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
  • ラテンアメリカ
  • 中東・アフリカ
• 価格分析
• ポーターのファイブフォース分析

第5章 マルチプレックスアッセイ市場の評価：タイプ別

• 概要
• タンパク質マルチプレックスアッセイ
  • ビーズベースアッセイ
  • 平面アッセイ
• 核酸マルチプレックスアッセイ
• 細胞ベースマルチプレックスアッセイ

第6章 マルチプレックスアッセイ市場評価：製品別

• 概要
• 消耗品
• 機器
• ソフトウェアとサービス

第7章 マルチプレックスアッセイ市場の評価：技術別

• 概要
• フローサイトメトリー
• マルチプレックスイムノアッセイ
• マルチプレックスリアルタイムPCR
• シーケンシング
• その他の技術

第8章 マルチプレックスアッセイ市場評価：用途別

• 概要
• 研究開発
• 診断
  • 感染症
  • 腫瘍学
  • 循環器疾患
  • 自己免疫疾患
  • その他の疾患

第9章 マルチプレックスアッセイ市場の評価：エンドユーザー別

• 概要
• 製薬・バイオテクノロジー企業
• 診断研究所
• 病院
• その他のエンドユーザー

第10章 マルチプレックスアッセイ市場の評価：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ

第11章 競合分析

• 概要
• 主要成長戦略
• 競合ベンチマーキング
• 競合ダッシュボード
  • 業界リーダー
  • 差別化要因
  • 先行企業
  • 新興企業

第12章 企業プロファイル（企業概要、財務スナップショット、製品ポートフォリオ、戦略的展開）

• Seegene, Inc.
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• QIAGEN N.V.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• DiaSorin S.p.A.
• PerkinElmer, Inc.
• Agilent Technologies, Inc.
• Abbott Laboratories
• Siemens Healthineers AG
• Merck KGaA
• Quanterix Corporation

（注：SWOT分析は上位5社について記載）

第13章 付録

List of Tables

• Table 1 Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
• Table 2 Some of The Emergency Use Authorizations (EUA) Granted for Multiplex Assays During the Covid-19 Pandemic
• Table 3 Medical Devices Regulatory Authorities in the Rest of APAC Countries
• Table 4 IVD Regulatory Systems, by Country
• Table 5 Average Selling Price of Multiplex Assays Products (Price/ USD)
• Table 6 Thermo Fisher Scientific, Inc. (U.S.): Multiplex Assays Prices
• Table 7 R&D Systems (U.S.): Multiplex Assays Prices
• Table 8 Quanterix Corporation (U.S.): Multiplex Assays Prices
• Table 9 Global Multiplex Assays Market, by Type, 2021- 2030 (USD Million)
• Table 10 Global Protein Multiplex Assays Market, by Type, 2021- 2030 (USD Million)
• Table 11 Global Protein Multiplex Assays Market, by Country/Region, 2021- 2030 (USD Million)
• Table 12 Global Multiplex Assays Market for Bead-based Assays, by Country/Region, 2021- 2030 (USD Million)
• Table 13 Global Multiplex Assays Market for Planar Assays, by Country/Region, 2021-2030 (USD Million)
• Table 14 Global Multiplex Assays Market for Nucleic Acid Multiplex Assays, by Country/Region, 2021-2030 (USD Million)
• Table 15 Global Multiplex Assays Market for Cell-Based Multiplex Assays, by Country/Region, 2021-2030 (USD Million)
• Table 16 Global Multiplex Assays Market, by Product, 2021- 2030 (USD Million)
• Table 17 Key Companies Offering Consumables for Multiplex Assays
• Table 18 Global Multiplex Assays Market for Consumables, by Country/Region, 2021-2030 (USD Million)
• Table 19 Global Multiplex Assays Market for Instruments, by Country/Region, 2021-2030 (USD Million)
• Table 20 Key Companies Offering Software
• Table 21 Global Multiplex Assays Market for Software & Services, by Country/Region, 2021-2030 (USD Million)
• Table 22 Global Multiplex Assays Market, by Technology, 2021- 2030 (USD Million)
• Table 23 Global Multiplex Assays Market for Flow Cytometry, by Country/Region, 2021-2030 (USD Million)
• Table 24 Global Multiplex Assays Market for Multiplex Immunoassay, by Country/Region, 2021-2030 (USD Million)
• Table 25 Global Multiplex Assays Market for Multiplex Real-Time PCR, by Country/Region, 2021-2030 (USD Million)
• Table 26 Global Multiplex Assays Market for Sequencing, by Country/Region, 2021-2030 (USD Million)
• Table 27 Global Multiplex Assays Market for Other Technologies, by Country/Region, 2021-2030 (USD Million)
• Table 28 Global Multiplex Assays Market, by Application, 2021- 2030 (USD Million)
• Table 29 Global Multiplex Assays Market for Research & Development, by Country/Region, 2021-2030 (USD Million)
• Table 30 Global Multiplex Assays Market for Clinical Diagnosis, by Type, 2021-2030 (USD Million)
• Table 31 Global Multiplex Assays Market for Clinical Diagnosis, by Country/Region, 2021-2030 (USD Million)
• Table 32 COVID-19 Testing Kits
• Table 33 Global Multiplex Assays Market for Infectious Diseases, by Country/Region, 2021-2030 (USD Million)
• Table 34 Global Multiplex Assays Market for Oncology, by Country/Region, 2021-2030 (USD Million)
• Table 35 Global Multiplex Assays Market for Cardiovascular Diseases, by Country/Region, 2021-2030 (USD Million)
• Table 36 Global Multiplex Assays Market, For Autoimmune Diseases, by Country/Region, 2021-2030 (USD Million)
• Table 37 Global Multiplex Assays Market for Other Diseases, by Country/Region, 2021-2030 (USD Million)
• Table 38 Global Multiplex Assays Market, by End User, 2021- 2030 (USD Million)
• Table 39 Global Multiplex Assays Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
• Table 40 Global Multiplex Assays Market for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
• Table 41 Global Multiplex Assays Market for Hospitals, by Country/Region, 2021-2030 (USD Million)
• Table 42 Global Multiplex Assays Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
• Table 43 Global Multiplex Assays Market, by Country/Region, 2021- 2030 (USD Million)
• Table 44 North America: Multiplex Assays Market, by Country, 2021-2030 (USD Million)
• Table 45 North America: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 46 North America: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 47 North America: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 48 North America: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 49 North America: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 50 North America: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 51 North America: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 52 U.S.: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 53 U.S.: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 54 U.S.: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 55 U.S.: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 56 U.S.: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 57 U.S.: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 58 U.S.: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 59 Canada: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 60 Canada: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 61 Canada: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 62 Canada: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 63 Canada: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 64 Canada: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 65 Canada: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 66 Europe: Multiplex Assays Market, by Country/Region, 2021-2030 (USD Million)
• Table 67 Europe: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 68 Europe: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 69 Europe: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 70 Europe: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 71 Europe: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 72 Europe: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 73 Europe: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 74 Germany: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 75 Germany: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 76 Germany: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 77 Germany: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 78 Germany: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 79 Germany: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 80 Germany: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 81 France: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 82 France: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 83 France: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 84 France: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 85 France: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 86 France: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 87 France: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 88 U.K.: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 89 U.K.: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 90 U.K.: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 91 U.K.: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 92 U.K.: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 93 U.K.: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 94 U.K.: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 95 Italy: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 96 Italy: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 97 Italy: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 98 Italy: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 99 Italy: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 100 Italy: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 101 Italy: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 102 Spain: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 103 Spain: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 104 Spain: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 105 Spain: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 106 Spain: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 107 Spain: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 108 Spain: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 109 COVID-19 Cases in European Countries
• Table 110 Rest of Europe: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 111 Rest of Europe: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 112 Rest of Europe: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 113 Rest of Europe: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 114 Rest of Europe: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 115 Rest of Europe: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 116 Rest of Europe: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 117 Asia-Pacific: Multiplex Assays Market, by Country/Region, 2021-2030 (USD Million)
• Table 118 Asia-Pacific: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 119 Asia-Pacific: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 120 Asia-Pacific: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 121 Asia-Pacific: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 122 Asia-Pacific: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 123 Asia-Pacific: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 124 Asia-Pacific: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 125 China: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 126 China: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 127 China: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 128 China: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 129 China: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 130 China: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 131 China: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 132 Japan: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 133 Japan: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 134 Japan: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 135 Japan: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 136 Japan: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 137 Japan: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 138 Japan: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 139 India: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 140 India: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 141 India: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 142 India: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 143 India: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 144 India: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 145 India: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 146 Rest of Asia-Pacific: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 147 Rest of Asia-Pacific: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 148 Rest of Asia-Pacific: Multiplex Assays Market, by Product, 2021- 2030 (USD Million)
• Table 149 Rest of Asia-Pacific: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 150 Rest of Asia-Pacific: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 151 Rest of Asia-Pacific: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 152 Rest of Asia-Pacific: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 153 Latin America: Multiplex Assays Market, by Country/Region, 2021-2030 (USD Million)
• Table 154 Latin America: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 155 Latin America: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 156 Latin America: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 157 Latin America: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 158 Latin America: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 159 Latin America: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 160 Latin America: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 161 Brazil: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 162 Brazil: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 163 Brazil: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 164 Brazil: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 165 Brazil: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 166 Brazil: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 167 Brazil: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 168 Mexico: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 169 Mexico: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 170 Mexico: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 171 Mexico: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 172 Mexico: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 173 Mexico: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-203 ( USD Million)
• Table 174 Mexico: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 175 Rest of Latin America: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 176 Rest of Latin America: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 177 Rest of Latin America: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
• Table 178 Rest of Latin America: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
• Table 179 Rest of Latin America: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
• Table 180 Rest of Latin America: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
• Table 181 Rest of Latin America: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
• Table 182 Middle East & Africa: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 183 Middle East & Africa: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
• Table 184 Middle East & Africa: Multiplex Assays Market, by Product, 2021- 2030 (USD Million)
• Table 185 Middle East & Africa: Multiplex Assays Market, by Technology, 2021- 2030 (USD Million)
• Table 186 Middle East & Africa: Multiplex Assays Market, by Application, 2021- 2030 (USD Million)
• Table 187 Middle East & Africa: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021- 2030 (USD Million)
• Table 188 Middle East & Africa: Multiplex Assays Market, by End User, 2021- 2030 (USD Million)
• Table 189 Recent Developments, by Company, 2020-2023

Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases) Product, End User-Global Forecast to 2030

The global multiplex assays market is expected to reach $6.24 billion by 2030 at a CAGR of 9.0% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is attributed to several factors, the advantages of multiplex assays over singleplex assays, the use of multiplexing in companion diagnostics, the increasing prevalence of chronic and infectious diseases, and rising awareness about the importance of early disease diagnosis. However, the high costs of multiplex assay equipment restrain the growth of this market.

The growing need for high-throughput and automated laboratory systems and the increasing focus on personalized medicine is expected to generate growth opportunities for the players operating in this market. However, the shortage of skilled professionals and the risk of cross-reactivity are major challenges to market growth.

Among all the types studied in this report, in 2023 protein multiplex assays segment is expected to account for the largest share of the multiplex assays market. Protein multiplex assays are further segmented into bead-based assays and planar assays. In 2023, the bead-based assays segment is expected to account for the largest share of the protein multiplex assays market. Multiplex bead-based assays have become essential tools for diagnosing various diseases. These assays are used for testing allergies, cancer markers, cytokines, cardiac markers, autoimmune diseases, and endocrine diseases. Bead-based assays offer a dynamic range of analytes as they are measured using flow cytometry. They are suitable for high-throughput analysis and are much more rapid, making them the preferred alternative to planar assays.

Among all the products studied in this report, in 2023, the consumables segment is expected to account for the largest share of the multiplex assays market. The large market share of this segment is attributed to the repetitive use of kits, the growing portfolio of disease-specific kits for early diagnosis of diseases, and the increasing product approvals. The continuous advancements in reagents and kits, the development of user-friendly diagnostic kits, and the adoption of multiplex assay kits in clinical and research laboratories positively impact the demand for consumables used in multiplex assays.

Among all the technologies studied in this report, the flow cytometry segment is projected to register the highest CAGR during the forecast period. Flow cytometry is considered an important tool in clinical diagnosis and research & development. It provides a multiparametric analysis of many single cells, which can be used in multiple research areas. Additionally, market players are launching advanced flow cytometers to support growing market needs. For instance, in June 2023, Becton, Dickinson and Company (U.S.) launched a BD FACSDuet to automate sample preparation during clinical flow cytometry diagnostics.

Among all the applications studied in this report, in 2023, the research & development segment is expected to account for the largest share of the multiplex assays market. The large market share of this segment is attributed to increasing applications of multiplex assays in drug discovery, biomarker profiling, and understanding disease mechanisms. The demand for multiplex assays in research & development is increasing rapidly and is also contributing to the largest share of the segment.

Among all the end users studied in this report, the research & development segment is expected to grow at the highest CAGR during the forecast period. The highest CAGR of this segment is attributed to factors such as the increasing R&D investments by pharmaceutical & biotechnology companies, the widespread utilization of multiplex assays in drug discovery & development, and a growing emphasis on personalized medicine research. The rising spending on R&D by pharmaceutical companies is also contributing to the largest share of this segment.

An in-depth analysis of the geographical scenario of the global multiplex assays market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the multiplex assays market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America's large share is attributed to the region's high R&D spending by the pharmaceutical & biotechnology companies for the development of drugs and biomarker identification, increasing prevalence of chronic diseases, rising healthcare expenditure, presence of leading market players in the region, and favorable government initiatives for research & development. According to the U.S. Congressional Budget Office, U.S. pharmaceutical R&D expenditure increased from 91.1 billion in 2020 to 102.3 billion in 2021.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years (2020-2023). The key players operating in the global multiplex assays market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Seegene, Inc. (South Korea), Qiagen N.V. (Netherlands), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Illumina, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Quanterix Corporation (U.S.), DiaSorin S.p.A. (Italy), and Merck KGaA (Germany).

Scope of the Report:

Multiplex Assays Market Assessment, by Type

• Protein Multiplex Assays
• Bead-based Assays
• Planar Assay
• Nucleic Acid Multiplex Assays
• Cell-based Multiplex Assays

Multiplex Assays Market Assessment, by Product

• Consumables
• Instruments
• Software & Services

Multiplex Assays Market Assessment, by Technology

• Flow Cytometry
• Multiplex Immunoassay
• Multiplex Real-Time PCR
• Sequencing
• Other Technologies

Note: Other technologies consist of microarray and immunohistochemistry

Multiplex Assays Market Assessment, by Application

• Research & Development
• Clinical Diagnosis
• Infectious Diseases
• Oncology
• Cardiovascular Diseases
• Autoimmune Diseases
• Other Diseases

Note: Other diseases include neurological diseases, thrombosis, and drug abuse testing.

Multiplex Assays Market Assessment, by End User

• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Hospitals
• Other End Users

Note: Other end users consist of academic institutes & research centers, forensic labs, agriculture companies, and food & beverage companies

Multiplex Assays Market Assessment, by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe (Roe)
• Asia-Pacific (APAC)
• China
• Japan
• India
• Rest of Asia-Pacific (RoAPAC)
• Latin America
• Brazil
• Mexico
• Rest of Latin America (RoLATAM)
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency And Limitations
• 1.4. Key stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
• 2.4. Assumptions for the study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Market Dynamics
    • 4.2.1.1. Advantages of Multiplex Assays over Singleplex Assays Leading to Their Increased Adoption
    • 4.2.1.2. Growing Use of Multiplexing in Companion Diagnostics Driving the Demand for Multiplex Assays
    • 4.2.1.3. High Costs of Multiplex Assay Equipment Hampering Adoption Among End Users
    • 4.2.1.4. Increasing Focus on Personalized Medicine Boosting the Utilization of Multiplex Assays
    • 4.2.1.5. Shortage of Skilled Professionals and the Risk of Cross-reactivity Limiting the Adoption of Multiplex Assays
  • 4.2.2. Factor Analysis
• 4.3. Technology Trends
  • 4.3.1. Technological Advancements in Multiplex PCR Technology
  • 4.3.2. Integration of Artificial Intelligence and Machine Learning into Multiplex Assay Systems
  • 4.3.3. Development of Smartphone-based Diagnostic Testing Platforms
• 4.4. Regulatory Analysis
  • 4.4.1. North America
    • 4.4.1.1. U.S.
    • 4.4.1.2. Canada
  • 4.4.2. Europe
  • 4.4.3. Asia-Pacific
    • 4.4.3.1. China
    • 4.4.3.2. India
    • 4.4.3.3. Japan
    • 4.4.3.4. South Korea
  • 4.4.4. Latin America
  • 4.4.5. Middle East & Africa
• 4.5. Pricing Analysis
• 4.6. Porter's Five Forces Analysis
  • 4.6.1. Bargaining Power of Suppliers
  • 4.6.2. Bargaining Power of Buyers
  • 4.6.3. Threat of Substitutes
  • 4.6.4. Threat of New Entrants
  • 4.6.5. Degree of Competition

5. Multiplex Assays Market Assessment-by Type

• 5.1. Overview
• 5.2. Protein Multiplex Assays
  • 5.2.1. Bead-based Assays
  • 5.2.2. Planar Assays
• 5.3. Nucleic Acid Multiplex Assays
• 5.4. Cell-based Multiplex Assays

6. Multiplex Assays Market Assessment- by Product

• 6.1. Overview
• 6.2. Consumables
• 6.3. Instruments
• 6.4. Software & Services

7. Multiplex Assays Market Assessment- by Technology

• 7.1. Overview
• 7.2. Flow Cytometry
• 7.3. Multiplex Immunoassay
• 7.4. Multiplex Real-time PCR
• 7.5. Sequencing
• 7.6. Other Technologies

8. Multiplex Assays Market Assessment- by Application

• 8.1. Overview
• 8.2. Research & Development
• 8.3. Clinical Diagnosis
  • 8.3.1. Infectious Diseases
  • 8.3.2. Oncology
  • 8.3.3. Cardiovascular Diseases
  • 8.3.4. Autoimmune Diseases
  • 8.3.5. Other Diseases

9. Multiplex Assays Market Assessment- by End User

• 9.1. Overview
• 9.2. Pharmaceutical & Biotechnology Companies
• 9.3. Diagnostic Laboratories
• 9.4. Hospitals
• 9.5. Other End Users

10. Multiplex Assays Market Assessment-by Geography

• 10.1. Overview
• 10.2. North America
  • 10.2.1. U.S.
  • 10.2.2. Canada
• 10.3. Europe
  • 10.3.1. Germany
  • 10.3.2. France
  • 10.3.3. U.K.
  • 10.3.4. Italy
  • 10.3.5. Spain
  • 10.3.6. Rest of Europe
• 10.4. Asia-Pacific
  • 10.4.1. China
  • 10.4.2. Japan
  • 10.4.3. India
  • 10.4.4. Rest of Asia-Pacific
• 10.5. Latin America
  • 10.5.1. Brazil
  • 10.5.2. Mexico
  • 10.5.3. Rest of Latin America
• 10.6. Middle East & Africa

11. Competition Analysis

• 11.1. Overview
• 11.2. Key Growth Strategies
• 11.3. Competitive Benchmarking
• 11.4. Competitive Dashboard
  • 11.4.1. Industry Leaders
  • 11.4.2. Differentiators
  • 11.4.3. Vanguards
  • 11.4.4. Emerging Companies

12. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)

• 12.1. Seegene, Inc.
• 12.2. F. Hoffmann-La Roche Ltd.
• 12.3. Thermo Fisher Scientific, Inc.
• 12.4. Illumina, Inc.
• 12.5. QIAGEN N.V.
• 12.6. Becton, Dickinson and Company
• 12.7. Bio-Rad Laboratories, Inc.
• 12.8. DiaSorin S.p.A.
• 12.9. PerkinElmer, Inc.
• 12.10. Agilent Technologies, Inc.
• 12.11. Abbott Laboratories
• 12.12. Siemens Healthineers AG
• 12.13. Merck KGaA
• 12.14. Quanterix Corporation

(Note: SWOT analysis is provided for the top 5 companies)

13. Appendix

• 13.1. Available Customization
• 13.2. Related Reports